Business Context and Reporting Period
Company: The Joint Corp. (JYNT)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2024
Business Overview: The Joint operates and franchises chiropractic clinics across the United States. As of June 30, 2024, the system included 960 clinics (829 franchised, 131 company-owned/managed). The company is executing a strategic shift to re-franchise or sell the majority of its company-owned clinics to leverage its franchise-building capacity.
Key Financial Metrics
| Metric (Six Months Ended June 30, 2024) | Value |
|---|---|
| Total Revenues | $59.98 million |
| Net Loss | $(2.65) million |
| Loss Per Share (Diluted) | $(0.18) |
| Operating Cash Flow | $1.84 million |
| Cash and Cash Equivalents | $17.46 million |
| Debt (Credit Agreement) | $0 (Paid down in Q1 2024) |
| Adjusted EBITDA | $5.63 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 4.1% to $59.98 million for the six months ended June 30, 2024, compared to $57.61 million in the prior year period. This was driven by a 9.9% increase in royalty fees and a 14.6% increase in software fees due to franchise base expansion.
- Profitability Decline: The company reported a net loss of $2.65 million for the six months ended June 30, 2024, compared to a net income of $2.01 million in the same period in 2023. The prior year included a one-time $3.8 million Employee Retention Credit (ERC) benefit.
- Expense Increases: General and administrative expenses rose 7.2% to $42.83 million, primarily due to $1.5 million in litigation and settlement costs related to employment matters outside the normal course of business.
- Impairment Charges: The company recorded a net loss on disposition or impairment of $1.80 million, largely due to write-downs on assets held for sale as part of the re-franchising strategy.
- Debt Reduction: The company fully repaid its $2.0 million outstanding balance under its Credit Agreement in January 2024.
Guidance, Outlook, and Risks
- Strategic Outlook: Management plans to continue re-franchising company-owned clinics, aiming to generate capital for reinvestment in the brand, IT platforms, or potential stock repurchases. The company expects to use existing cash and operating cash flows to fund operations for the next 12 months.
- Operational Trends: System-wide comparable sales for clinics open at least 13 months increased 2% in Q2 2024. However, mature clinics (open 48+ months) saw a 4% decrease in comparable sales.
- Risks and Contingencies:
- Labor Market: Ongoing labor shortages and wage inflation are increasing costs and impacting recruitment.
- Legal: Significant litigation expenses ($1.5 million) were incurred in the first half of 2024 regarding employment matters.
- Internal Controls: The company has previously identified material weaknesses in internal controls over financial reporting and has restated prior financial statements.
- Regulatory: Risks related to state laws regarding the corporate practice of chiropractic and potential joint employer liability.
Investor Verification Checklist
- Recurring vs. One-Time Items: Verify the sustainability of the $1.5 million litigation expense and confirm if similar legal costs are expected in future quarters.
- Re-franchising Progress: Monitor the pace of selling company-owned clinics (currently ~76% of the portfolio targeted) and the associated impairment charges.
- Labor Cost Inflation: Assess the impact of rising wages on the margins of company-owned clinics versus the royalty-based franchise model.
- Internal Controls: Review the status of remediation efforts for previously identified material weaknesses in financial reporting.
- Cash Flow Sustainability: Confirm that operating cash flows remain sufficient to cover expenses without the one-time ERC benefit received in 2023.